NCT06735118View on ClinicalTrials.gov

Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver

NARecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 25, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DRUG

Neoadjuvant chemotherapy

Neoadjuvant chemotherapy

Trial Locations (1)

650118

RECRUITING

Yunnan Cancer Hospital, Kunming

All Listed Sponsors

lead

Yunnan Cancer Hospital

OTHER